Novel and emerging therapies in the treatment of recessive dystrophic epidermolysis bullosa

E Rashidghamat, JA McGrath - Intractable & Rare Diseases …, 2017 - jstage.jst.go.jp
Epidermolysis bullosa (EB) is a clinically and genetically heterogeneous group of inherited
blistering diseases that affects~ 500,000 people worldwide. Clinically, individuals with EB …
被引用次数：111 相关文章
[PDF] rareconnect.org

[PDF][PDF] Novel and emerging therapies in the treatment of recessive dystrophic epidermolysis bullosa

E Rashidghamat, JA McGrath - rareconnect.org
Epidermolysis bullosa (EB) is a clinically and genetically heterogeneous group of inherited
blistering diseases that affects~ 500,000 people worldwide. Clinically, individuals with EB …

Novel and emerging therapies in the treatment of recessive dystrophic epidermolysis bullosa

E Rashidghamat, JA McGrath - Intractable & rare …, 2017 - pubmed.ncbi.nlm.nih.gov
Epidermolysis bullosa (EB) is a clinically and genetically heterogeneous group of inherited
blistering diseases that affects∼ 500,000 people worldwide. Clinically, individuals with EB …

Novel and emerging therapies in the treatment of recessive dystrophic epidermolysis bullosa.

E Rashidghamat, JA McGrath - Intractable & Rare Diseases …, 2017 - europepmc.org
Epidermolysis bullosa (EB) is a clinically and genetically heterogeneous group of inherited
blistering diseases that affects~ 500,000 people worldwide. Clinically, individuals with EB …
[PDF] kcl.ac.uk

[PDF][PDF] Novel and emerging therapies in the treatment of recessive dystrophic epidermolysis bullosa

E Rashidghamat, JA McGrath - kclpure.kcl.ac.uk
Epidermolysis bullosa (EB) is a clinically and genetically heterogeneous group of inherited
blistering diseases that affects~ 500,000 people worldwide. Clinically, individuals with EB …

[引用][C] Novel and emerging therapies in the treatment of recessive dystrophic epidermolysis bullosa

E Rashidghamat, JA McGrath - Intractable & Rare Diseases …, 2017 - jglobal.jst.go.jp
Novel and emerging therapies in the treatment of recessive dystrophic epidermolysis
bullosa | Article Information | J-GLOBAL Art J-GLOBAL ID:201702288499479181 Reference …

Novel and emerging therapies in the treatment of recessive dystrophic epidermolysis bullosa

R Ellie - Intractable & Rare Diseases Research, 2017 - cir.nii.ac.jp
抄録< p> Epidermolysis bullosa (EB) is a clinically and genetically heterogeneous group of
inherited blistering diseases that affects~ 500,000 people worldwide. Clinically, individuals …
[HTML] nih.gov

[HTML][HTML] Novel and emerging therapies in the treatment of recessive dystrophic epidermolysis bullosa

E Rashidghamat, JA McGrath - Intractable & Rare Diseases …, 2017 - ncbi.nlm.nih.gov
Epidermolysis bullosa (EB) is a clinically and genetically heterogeneous group of inherited
blistering diseases that affects∼ 500,000 people worldwide. Clinically, individuals with EB …

Novel and emerging therapies in the treatment of recessive dystrophic epidermolysis bullosa

E Rashidghamat, JA McGrath - Intractable & Rare Diseases …, 2017 - jstage.jst.go.jp
Epidermolysis bullosa (EB) is a clinically and genetically heterogeneous group of inherited
blistering diseases that affects~ 500,000 people worldwide. Clinically, individuals with EB …

Novel and emerging therapies in the treatment of recessive dystrophic epidermolysis bullosa.

E Rashidghamat, JA McGrath - Intractable & Rare Diseases …, 2017 - europepmc.org
Epidermolysis bullosa (EB) is a clinically and genetically heterogeneous group of inherited
blistering diseases that affects~ 500,000 people worldwide. Clinically, individuals with EB …